SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-071417
Filing Date
2020-06-09
Accepted
2020-06-09 16:33:57
Documents
1
Period of Report
2020-06-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2022128-3_4.html 4  
1 OWNERSHIP DOCUMENT tm2022128-3_4.xml 4 4581
  Complete submission text file 0001104659-20-071417.txt   6186
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Business Address
COLLIER EARL M JR (Reporting) CIK: 0001201254 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 20952275